This finding is corroborated by another study on circulating TRM cells (36) suggesting that upon re-exposure to tumor antigens, CD103+CD8+ T cells differentiate into effector cells, such as TCM and TEM cells, thereby exerting an antitumor function. The gene discussed is ITGAE; the disease is neoplasm.